GE HealthCare Technologies Inc. reported its financial results for the third quarter and the first nine months of 2025, revealing total revenues of $5.143 billion for the quarter, a 6% increase from $4.863 billion in the same period last year. For the nine months ended September 30, 2025, revenues reached $14.927 billion, up 4% from $14.353 billion in 2024. The company's net income attributable to GE HealthCare for the third quarter was $446 million, down from $470 million a year earlier, while net income for the nine months increased to $1.495 billion from $1.272 billion.

The company experienced notable growth in its product and service sales, with product sales rising to $3.375 billion in the third quarter, a 5% increase from $3.201 billion in 2024. Service sales also grew by 6% to $1.769 billion, compared to $1.662 billion in the prior year. The growth was primarily driven by strong performance in the Pharmaceutical Diagnostics (PDx) segment, which saw a 20% increase in revenues, largely due to the acquisition of Nihon Medi-Physics Co., Ltd. (NMP). However, the Patient Care Solutions (PCS) segment reported a decline of 6% in revenues, attributed to a product hold.

In terms of operational developments, GE HealthCare's total assets increased to $36.127 billion as of September 30, 2025, up from $33.089 billion at the end of 2024. The company also reported a significant increase in cash and cash equivalents, which rose to $4.027 billion from $2.889 billion. The company’s employee headcount remained stable, with no significant changes reported. GE HealthCare continues to focus on strategic acquisitions, including the planned acquisition of icometrix NV, aimed at enhancing its neurological care offerings.

Looking ahead, GE HealthCare anticipates continued challenges due to macroeconomic factors, including tariffs and geopolitical tensions, which may impact profitability and cash flows. The company is actively monitoring market conditions, particularly in China, where government stimulus programs are expected to create long-term opportunities despite short-term delays in purchasing decisions. The company remains committed to optimizing its operations and managing costs effectively to navigate these challenges.

About GE HealthCare Technologies Inc.

GE Healthcare Technologies Inc. is a global provider of medical imaging, diagnostic, and patient monitoring equipment, along with digital and AI-enabled healthcare solutions. Its core segments include Imaging, Advanced Visualization Solutions, Patient Care Solutions, and Pharmaceutical Diagnostics. Serving healthcare providers worldwide, the company focuses on precision medicine, clinical decision support, and improving patient outcomes through innovative technology, comprehensive services, and a broad product portfolio.

This description was generated via AI from an annual report. Updated 8 months ago.

About 10-Q Filings

A 10-Q form is an important financial report that public companies in the United States must submit every three months. It gives a clear picture of a company's financial health and recent performance.

Key points about the 10-Q:

  • Frequency: Companies file it three times a year, covering the first three quarters. The fourth quarter is covered in a more comprehensive annual report.
  • Content: It includes:
    • Financial statements showing the company's current financial position
    • Updates from management on the performance and projections of the business
    • Information about potential risks the company faces
    • Details on how the company is run internally
  • Deadline: Must be filed within 40 or 45 days after the quarter ends, depending on the size of the company.

Our Methodology

AssetRoom is committed to providing timely summaries of news from public companies. We use AI to generate these summaries quickly, but they are not reviewed by human experts.

Our method:

  1. Data Collection: We continuously monitor for new filings (currently limited to US-listed stocks).
  2. AI-Powered Analysis: Our advanced AI system processes each filing, identifying key information and extracting relevant data.
  3. Summary Generation: The AI creates a concise, easy-to-understand summary of the filing, highlighting the most important points.
  4. Publication: The summary is immediately published on our platform, allowing users instant access to the latest information.
  5. Email users: We distribute round-up emails according to our users preferences, keeping them in the loop with the companies they follow.
Read more about AssetRoom

Feedback & Corrections

Spot an error or have a suggestion? Contact us.